Cargando...
Quinuclidine-Based Carbamates as Potential CNS Active Compounds
The treatment of central nervous system (CNS) diseases related to the decrease of neurotransmitter acetylcholine in neurons is based on compounds that prevent or disrupt the action of acetylcholinesterase and butyrylcholinesterase. A series of thirteen quinuclidine carbamates were designed using qui...
Gardado en:
| Publicado en: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8003920/ https://ncbi.nlm.nih.gov/pubmed/33804719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13030420 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|